Immunohistochemistry (IHC) revealed that all tumor samples expressed BRAFV600E, while p-AKT, a hallmark of PTEN inactivation, was only detected in samples with ptena/b KO (Figure 5E). This evidence concerns the gene PTEN and neoplasm.